Section Arrow
Quote
NVNO.NASDAQ
- enVVeno Medical Corporation
Quotes are at least 15-min delayed:2026/03/09 17:57 EDT
After Hours
Last
 11.83
0 (0.00%)
Bid
11
Ask
12.5
High 11.83 
Low 11.83 
Volume 2 
Regular Hours (Closed)
Last
 11.83
+0.38 (+3.32%)
Day High 
11.9799 
Prev. Close
11.45 
1-M High
12.85 
Volume 
154 
Bid
11
Ask
12.5
Day Low
10.21 
Open
11.44 
1-M Low
8.67 
Market Cap 
7.51M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 10.88 
20-SMA 10.32 
50-SMA 11.02 
52-W High 196.7 
52-W Low 0.891 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-37.80/-0.45
Enterprise Value
8.21M
Balance Sheet
Book Value Per Share
44.92
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
422.11K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories112.65+3.09+2.82%29.21PE
After Hours 112.0197 -0.6303 -0.56%
BSXBoston Scientific Corp71.9+0.55+0.77%36.78PE
After Hours 71.39 -0.51 -0.71%
MDTMedtronic plc91.34+0.44+0.48%25.39PE
After Hours 91.25 -0.09 -0.10%
BFLYButterfly Network3.76+0.11+3.01%-- 
After Hours 3.74 -0.02 -0.53%
PACBPacific Biosciences of California1.39+0.01+0.72%-- 
After Hours 1.4 +0.01 +0.72%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in asingle geographic location, the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.